Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
CRVS
CRVS News & Events
-
Add to Watchlist
Trade CRVS
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
News
CRVS News
Corvus Pharmaceuticals (CRVS) Stock Soars 211.8% to New All-Time High
2 days ago
Yahoo Finance
Corvus Pharmaceuticals Upsizes Stock Offering to $175 Million for R&D and Working Capital
5 days ago
stocktwits
Corvus Pharmaceuticals Prices $175M Upsized Public Offering to Fund Clinical Trials
5 days ago
seekingalpha
Corvus Pharmaceuticals Prices Upsized Offering of 7.9 Million Shares at $22.15, Raising $175 Million
5 days ago
Yahoo Finance
Netflix Reports Q4 Results, Q1 Guidance Misses Estimates
6 days ago
Benzinga
Corvus Pharmaceuticals Initiates $150 Million Public Offering Amid 8.92% Stock Decline
6 days ago
NASDAQ.COM
U.S. Stocks Plunge as Trump Revives Tariff Threats
6 days ago
stocktwits
Corvus Pharmaceuticals Launches $150 Million Public Offering to Fund Clinical Trials
Jan 21 2026
stocktwits
Show More News
CRVS Events
01/22 08:40
Jefferies and Goldman Sachs Increase Deal Size to $175M
The deal size was increased to $175M in common stock from $150M in common stock. Jefferies and Goldman Sachs acted as joint book running managers for the offering.
Show More Events
CRVS Monitor News
Corvus Pharmaceuticals Prices $175M Upsized Public Offering
Jan 26 2026
Corvus Pharmaceuticals Reports Positive Trial Results and Upsizes Stock Offering
Jan 22 2026
Corvus Pharmaceuticals to Report Phase 1 Trial Results for Soquelitinib
Jan 20 2026
CRVS Earnings Analysis
No Data
People Also Watch
